DISCORDANT CALCIUM AND PARATHYROID HORMONE WITH PRESUMED EPILEPTIC SEIZURES
DOI:
https://doi.org/10.54112/bcsrj.v2023i1.314Keywords:
parathyroid hormone, calcium levels, abnormalities in calciumAbstract
Epileptic seizures are a neurological condition characterized by abnormal electrical activity in the brain, leading to involuntary and unpredictable movements, changes in consciousness, and other symptoms. The study's main objective is to find the discordant calcium and parathyroid hormone with presumed epileptic seizures. This study aims to investigate the association between discordant calcium and parathyroid hormone (PTH) levels and presumed epileptic seizures in a cohort of 200 patients. The study was conducted between June 2022 and December 2022. The study was conducted in collaboration with the neurology department. Patients admitted to the hospital with presumed epileptic seizures were included in the study. This study found that out % of the 200 patients who met the inclusion criteria, 65% had discordant calcium and PTH levels. Among these patients, 80% had low calcium and high PTH levels, while 20% had high calcium and low PTH levels. The logistic regression analysis showed a significant association between discordant calcium and PTH levels and presumed epileptic seizures (p<0.05). In conclusion, the results of this study suggest that abnormalities in calcium and parathyroid hormone (PTH) levels are not a major contributor to the development of epileptic seizures in most patients. While patients with hypocalcemia appeared to have a higher risk of seizures than those with normal calcium levels, most patients with hypocalcemia did not experience seizures.
Downloads
References
Aggarwal, S., Kailash, S., Sagar, R., Tripathi, M., Sreenivas, V., Sharma, R., . . . Goswami, R. (2013). Neuropsychological dysfunction in idiopathic hypoparathyroidism and its relationship with intracranial calcification and serum total calcium. European journal of endocrinology, 168(6), 895-903.
Bilezikian, J. P., Khan, A., Potts Jr, J. T., Brandi, M. L., Clarke, B. L., Shoback, D., . . . Rejnmark, L. (2011). Hypoparathyroidism in the adult: epidemiology, diagnosis, pathophysiology, target‐organ involvement, treatment, and challenges for future research. Journal of Bone and Mineral Research, 26(10), 2317-2337.
Bloem, B., & Stocchi, F. (2015). Move for Change Part III: a European survey evaluating the impact of the EPDA Charter for People with Parkinson's Disease. European journal of neurology, 22(1), 133-141.
Camacho, P. M., Petak, S. M., Binkley, N., Diab, D. L., Eldeiry, L. S., Farooki, A., . . . Lewiecki, E. M. (2020). American Association of Clinical Endocrinologists/American College of Endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis—2020 update. Endocrine Practice, 26, 1-46.
Chale-Matsau, B., Van Niekerk, C., Kemp, T., & Pillay, T. S. (2018). Discordant calcium and parathyroid hormone with presumed epileptic seizures. Clinical chemistry, 64(3), 442-445.
Dedivitis, R. A., Pfuetzenreiter Jr, E. G., Nardi, C. E. M., & Barbara, E. C. D. d. (2010). Prospective study of clinical and laboratorial hypocalcemia after thyroid surgery. Brazilian journal of otorhinolaryngology, 76, 71-77.
Goswami, R., Sharma, R., Sreenivas, V., Gupta, N., Ganapathy, A., & Das, S. (2012). Prevalence and progression of basal ganglia calcification and its pathogenic mechanism in patients with idiopathic hypoparathyroidism. Clinical endocrinology, 77(2), 200-206.
Heller, A., Chesterman, P., Elwes, R., Crawford, P., Chadwick, D., Johnson, A., & Reynolds, E. (1995). Phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed adult epilepsy: a randomised comparative monotherapy trial. Journal of Neurology, Neurosurgery & Psychiatry, 58(1), 44-50.
Liang, K.-G., Mu, R.-Z., Liu, Y., Jiang, D., Jia, T.-T., & Huang, Y.-J. (2019). Increased serum S100B levels in patients with epilepsy: a systematic review and meta-analysis study. Frontiers in neuroscience, 13, 456.
Liu, M.-J., Li, J.-W., Shi, X.-Y., Hu, L.-Y., & Zou, L.-P. (2017). Epileptic seizure, as the first symptom of hypoparathyroidism in children, does not require antiepileptic drugs. Child's Nervous System, 33, 297-305.
Luk, H., Lo, I., Tong, T., Lai, K., & Lam, S. (2015). Case Report Pseudohypoparathyroidism Type 1b: First Case Report in Chinese and Literature Review. HK J Paediatr (new series), 20(1), 32-36.
Moushumi, L., & Rajarshi, M. (2014). Primary Hypoparathyroidism Misdiagnosed as Epilepsy–A Case Report: Seizures, hypocalcemia and cerebral calcification. EJIFCC, 25(2), 195.
Perez-Nanclares, G., Velayos, T., Vela, A., Muñoz-Torres, M., & Castaño, L. (2015). Pseudohypoparathyroidism type Ib associated with novel duplications in the GNAS locus. PLoS One, 10(2), e0117691.
Pešić, M., Radojković, D., Radenković, S., Spasić, M., & Lukić, S. (2011). Epileptic seizure as the first sign of hypoparathyroidism. Vojnosanitetski pregled, 68(1), 81-84.
Runge, U., Arnold, S., Brandt, C., Reinhardt, F., Kühn, F., Isensee, K., . . . Noack‐Rink, M. (2015). A noninterventional study evaluating the effectiveness and safety of lacosamide added to monotherapy in patients with epilepsy with partial‐onset seizures in daily clinical practice: The VITOBA study. Epilepsia, 56(12), 1921-1930.
Saleem, S., Aslam, H. M., Anwar, M., Anwar, S., Saleem, M., Saleem, A., & Rehmani, M. A. K. (2013). Fahr’s syndrome: literature review of current evidence. Orphanet journal of rare diseases, 8(1), 1-9.
Westwood, A. C., & West, N. P. (2018). The importance of pathological quality control for rectal surgery. Mini-invasive Surgery, 2.
Zhong, Z., Wang, Z., Wang, Y., You, G., & Jiang, T. (2015). IDH1/2 mutation is associated with seizure as an initial symptom in low-grade glioma: a report of 311 Chinese adult glioma patients. Epilepsy research, 109, 100-105.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 M SALMAN, U AYMUN, S KHAWAR, B ASLAM, U ASLAM, T KHALID
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.